Table 2 compares the relationship between serum ICAM-1 levels in the COVID-19 and non-COVID-19 groups before and after debridement and with other COVID-19 criteria, such as high NLR value, pneumonia, leukopenia or leucocytosis, and lymphocytopenia. This evidence concerns the gene ICAM1 and susceptibility to pneumonia measurement.